TBR1-Related Neurocognitive Disorder: Lithium Carbonate Study

We are studying whether lithium carbonate can improve behavior and communication in patients with TBR1-related neurocognitive disorder. This trial will also assess the treatment's safety and overall impact on quality of life.

>2 years11-15 visitsSafety phase (I)Efficacy phase (II)Post-Trial Drug AccessNo PlaceboPartially RemoteInvestigational MedicinesOralNeurologyPsychiatry

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lithium Carbonate
Lithium carbonate is a substance that helps stabilize mood and prevent manic and depressive episodes in people with bipolar disorder.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Teralithe

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Bordeaux
Génétique Médicale
Bordeaux, France
Hospital Femme Mere Enfant
Génétique
Bron, France
Centre Hospitalier Universitaire De Lille
Génétique clinique Guy Fontaine
Loos, France
Sponsor: Centre Hospitalier Universitaire De Dijon
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.